DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

Borg Hemelaer

Business Development Officer

BePharbel Manufacturing

Courcelles, Belgium

15 profile visitsCompanies/Industry

My organisation

Bepharbel is a pharmaceutical CDMO specialized in liquid oral dosage forms. In parallel, the company has developed MMCR™, a proprietary liquid formulation platform technology enabling gastro‑resistant and prolonged release, and is now expanding this platform into veterinary development.
Read more

About me

Additional questions

Interests

Enabling technology (assay, delivery, formulation, manufacturing, ...)Companion animals

What is your primary goal for attending this event?

Seeking investment opportunitiesNetworking with industry professionalsExploring potential collaborationsShowcasing products or solutions

Marketplace (1)

  • Project cooperation

    MMCR formulation platform - co-development, licensing & investment.

    MMCR™ is a proprietary technology enabling gastro‑resistant and prolonged‑release properties in liquid formulations. Following human development, we aim to expand MMCR™ into companion animals and horses via co‑development and licensing.

    • Animal Health
    • Licensing Partner
    • Investment Partner
    • Distribution Partner
    • Research Collaboration
    • Commercialisation Partner
    • TRL 5: Technology validation in relevant environment
    Author

    Borg Hemelaer

    Business Development Officer at BePharbel Manufacturing

    Courcelles, Belgium